These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12107860)

  • 1. Decrease of energy expenditure causes weight increase in olanzapine treatment - a case study.
    Virkkunen M; Wahlbeck K; Rissanen A; Naukkarinen H; Franssila-Kallunki A
    Pharmacopsychiatry; 2002 May; 35(3):124-6. PubMed ID: 12107860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis.
    Graham KA; Perkins DO; Edwards LJ; Barrier RC; Lieberman JA; Harp JB
    Am J Psychiatry; 2005 Jan; 162(1):118-23. PubMed ID: 15625209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.
    Gothelf D; Falk B; Singer P; Kairi M; Phillip M; Zigel L; Poraz I; Frishman S; Constantini N; Zalsman G; Weizman A; Apter A
    Am J Psychiatry; 2002 Jun; 159(6):1055-7. PubMed ID: 12042200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine-induced weight gain.
    Gupta S; Droney T; Al-Samarrai S; Keller P; Frank B
    Ann Clin Psychiatry; 1998 Mar; 10(1):39. PubMed ID: 9622049
    [No Abstract]   [Full Text] [Related]  

  • 5. Weight gain and hyperglycaemia associated with olanzapine.
    Riccitelli G; Baker N
    Aust N Z J Psychiatry; 2002 Apr; 36(2):270-1. PubMed ID: 11982558
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
    Kinon BJ; Basson BR; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Feb; 62(2):92-100. PubMed ID: 11247108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of amantadine on weight gain during olanzapine treatment.
    Floris M; Lejeune J; Deberdt W
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):181-2. PubMed ID: 11313165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine increases weight and serum triglyceride levels.
    Osser DN; Najarian DM; Dufresne RL
    J Clin Psychiatry; 1999 Nov; 60(11):767-70. PubMed ID: 10584766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    Hum Psychopharmacol; 2003 Aug; 18(6):457-61. PubMed ID: 12923824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine induces remarkable weight gain in adolescent patients.
    Haapasalo-Pesu KM; Saarijärvi S
    Eur Child Adolesc Psychiatry; 2001 Sep; 10(3):205-8. PubMed ID: 11596822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased lean body mass as an early indicator of olanzapine-induced weight gain in healthy men.
    Daurignac E; Leonard KE; Dubovsky SL
    Int Clin Psychopharmacol; 2015 Jan; 30(1):23-8. PubMed ID: 25350366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia.
    Levy E; Margolese HC; Chouinard G
    J Clin Psychiatry; 2002 Nov; 63(11):1045. PubMed ID: 12469686
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse events related to olanzapine.
    Conley RR; Meltzer HY
    J Clin Psychiatry; 2000; 61 Suppl 8():26-9; discussion 30. PubMed ID: 10811240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Randomized, open label study on the use of ranitidine at different doses for the management of weight gain associated with olanzapine administration].
    López-Mato A; Rovner J; Illa G; Vieitez A; Boullosa O
    Vertex; 2003; 14(52):85-96. PubMed ID: 12883589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study.
    Poyurovsky M; Isaacs I; Fuchs C; Schneidman M; Faragian S; Weizman R; Weizman A
    Am J Psychiatry; 2003 Feb; 160(2):297-302. PubMed ID: 12562576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body weight gain, insulin, and leptin in olanzapine-treated patients.
    Baptista T; Beaulieu S
    J Clin Psychiatry; 2001 Nov; 62(11):902-4. PubMed ID: 11775052
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine: weight gain and therapeutic efficacy.
    Gupta S; Droney T; Al-Samarrai S; Keller P; Frank B
    J Clin Psychopharmacol; 1999 Jun; 19(3):273-5. PubMed ID: 10350036
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperglycemia from olanzapine treatment in adolescents.
    Bloch Y; Vardi O; Mendlovic S; Levkovitz Y; Gothelf D; Ratzoni G
    J Child Adolesc Psychopharmacol; 2003; 13(1):97-102. PubMed ID: 12804130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight gain associated with antipsychotic drugs.
    Ganguli R
    J Clin Psychiatry; 1999; 60 Suppl 21():20-4. PubMed ID: 10548138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.